biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Perhaps the greatest piece of investment wisdom ever...

<< Previous

Bullboard Posts

Next >>

Comment by InitiumMMXXIIIon Dec 06, 2023 3:51pm

81 Views

Post# 35771702

RE:RE:RE:RE:RE:RE:RE:RE:RE:Perhaps the greatest piece of investment wisdom ever...

Yes, it is true. I was a handshake partner of his at the time. The car was a Maserati Quattroporte. He buklt a house but couldn't afford it. Had to sell. I don't think he went bankrupt but he had a tough time for a while, all of it self-inflicted. I stepped away from those guys in 2014 when they started a rebellion against Bioasis. (I have documentation including their draft press release.) That's when I was hired by Bioasis.

I like being like you, TT. No threats. Just do it.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale